DOCN
DigitalOcean Holdings, Inc.
DOCN trails on the overall score without a compensating advantage in the available component scores.
SNDK
Sandisk Corporation
SNDK has the edge over DOCN overall, supported by stronger modeled upside and stronger valuation.
DOCN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
DOCN's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
DOCN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $7.61 | -92% |
| Fair | 46x | $13.68 | -85% |
| Forward | 55x | $90.07 | — |
| Expensive | 68x | $20.36 | -77% |
| Current | 300x | $90.07 | — |
Historical ranges are pointers, not guarantees.
DOCN's PE is in its expensive range at 300x. If earnings grow as analysts expect, today's price would be 55x next year's earnings, in its fair range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over DOCN in the historical PE scenario, which offers more potential upside but is not a forecast.
DOCN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for DOCN, but weaker profitability. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over DOCN on the outlook, with more favorable profitability expectations.
DOCN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.64 | +448% |
| Q3 2026 | $0.30 | -88% |
| Q2 2026 | $2.18 | +68% |
| Q1 2026 | $2.28 | +105% |
| Q4 2025 | $2.52 | +190% |
| Q3 2025 | $2.48 | +195% |
| Q2 2025 | $1.30 | +83% |
| Q1 2025 | $1.11 | +113% |
| Q4 2024 | $0.87 | +335% |
DOCN earned $0.30 per share over the past year, down 88% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over DOCN in the latest year-over-year earnings comparison.
DOCN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $321.2M | +40% |
| Q2 2026 | $281.2M | +29% |
| Q1 2026 | $257.9M | +22% |
| Q4 2025 | $242.4M | +18% |
| Q3 2025 | $229.6M | +16% |
| Q2 2025 | $218.7M | +14% |
| Q1 2025 | $210.7M | +14% |
| Q4 2024 | $204.9M | +13% |
DOCN's revenue has grown year over year every quarter since early 2021: $321M last quarter, up 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 10% | -9.3 points |
| Q2 2026 | 10% | -5.8 points |
| Q1 2026 | 14% | -3.7 points |
| Q4 2025 | 16% | +0.1 points |
| Q3 2025 | 20% | +7.2 points |
| Q2 2025 | 16% | +4.7 points |
| Q1 2025 | 18% | +12 points |
| Q4 2024 | 16% | +9.8 points |
DOCN's operating margin was 10% last quarter, down 9.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over DOCN on profitability, with a higher operating margin.
DOCN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $137.7M | +56% |
| Q2 2026 | $68.4M | +15% |
| Q1 2026 | $6.9M | +226% |
| Q4 2025 | $31.1M | +19% |
| Q3 2025 | $88M | +450% |
| Q2 2025 | $59.3M | +50% |
| Q1 2025 | $2.1M | -91% |
| Q4 2024 | $26.1M | -7.9% |
DOCN has the edge over SNDK on cash flow, with more consistent year-over-year improvement.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
DOCN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.4% | -11.9M shares |
| 1 year | +8.7% | +9.2M shares |
| 3 years | +12% | +12M shares |
| 5 years | +6.2% | +6.7M shares |
| Available history | +32% | +27.6M shares |
DOCN has 115M diluted shares, up 8.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $2.9M |
| Q2 2025 | $20.1M |
| Q1 2025 | $59.1M |
| Q4 2024 | $29.9M |
DOCN hasn't bought back shares in the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over DOCN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
DOCN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 3.5x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.3x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.8x | High |
DOCN has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
DOCN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.1 | Neutral |
| Stochastic | 11.0 | Oversold |
DOCN's weekly RSI is 42 (neutral) and its Stochastic is 11 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
DOCN PE vs Technology Sector
| Metric | DOCN | Sector median | Relative |
|---|---|---|---|
| PE | 300x | 28x | 978% above |
| PE % | 100 | 41 | 59 pts above |
DOCN is trading at 300x earnings, a 978% premium to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over DOCN on valuation relative to its sector.
DOCN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $107.3 | 16% below |
| 20 week MA | $116.3 | 23% below |
| 50 week MA | $101.1 | 11% below |
| 100 week MA | $68.0 | 33% above |
| 200 week MA | $51.5 | 75% above |
DOCN has stronger trend alignment. DOCN is above 2 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
DOCN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $41.6 | $81.3 | +95% |
| 2022 | $81.3 | $24.8 | -70% |
| 2023 | $24.8 | $36.7 | +48% |
| 2024 | $36.7 | $34.9 | -4.8% |
| 2025 | $34.9 | $49.5 | +42% |
| 2026 YTD | $49.5 | $90.1 | +82% |
DOCN has finished higher in three of the last five years. It's up 82% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over DOCN on returns for 2026, with the stronger performance.